Regulatory & Compliance

Understand This Before You Use AI To Build Software ft. Chris Guthrie

Hirsh Jain: Rescheduling Is Already Picking Winners

Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka

Why Ohio Cannabis Is Built Different: Inside the Regulator-Operator Alignment That's Actually Working ft. Caroline Henry

Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller

The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli

Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed

Prop 64 Fine Print, Pesticide Drift, The Economics Behind Concentrates ft. Micah Anderson

Cannabis Beverages Are Bringing New Consumers Into Cannabis ft Kristin & Eric Rogers

How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick

Schedule III Changes Everything — This Is Just the Beginning

What Tobacco and Alcohol Taught Me About Cannabis. ft. Nick Kenny

The Amazon of THC, How Edibles.com Will Take Cannabis National, ft. Thomas Winstanley

Chris Ball: Betting It All — What It Really Takes to Build a Brand With Your Name on It: Pain, Patience, and Relentless Faith

$28.4 Billion Dollar Hemp Industry Can’t Be Put Back in the Bottle ft Jim Higdon

Largest Medical Cannabis & Cancer Study Ever: Can These Findings Push Rescheduling? ft Ryan Castle

THC Is an Ingredient, Where Pharma, MSOs & Hemp Collide, ft. Zach Edge

Secrets Behind Failed Cannabis Builds: Where Every Team Needs to Look Now ft. David Fettner

Keep Your Eye on Ohio: Why California’s Failures Are Michigan’s Success, and the Global Cannabis Landscape ft. Hirsh Jain

Organigram’s Competitive Edge: Paolo De Luca on BAT, M&A Strategy, and the Cannabis Long Game

Trump, Texas SB3 & the Rescheduling Timeline: Jim Higdon on What Comes Next

Fix the Process: Real Cannabis Manufacturing Tools & Optimization Techniques ft.: Murphy Murri

Big Tobacco Is Moving on Cannabis, the Global Strategy Is Unfolding, and Deepak Anand Reveals Where’s Next

Why Cannabis Companies Must Face Reality, Make Hard Choices, and Follow the Data ft. AnnaRae Grabstein

How Leafwell is Disrupting Healthcare: The Data Doctors Can’t Ignore ft. Emily Fisher & Dr June Chin

The Hard Thing About Hard Things: A Melody of Grit & Fortitude ft. Christina Betancourt Johnson

Premium Should Mean Organic: How Jetty Extracts is Leading the Clean Cannabis Movement ft. Ron Gershoni

We Don’t Want Legalization—We Want Decriminalization ft. Luna Stower

China Tariffs & The Next Era of Vapes: Impact on Supply Chains & Brands ft. Nick Kovacevich

Why Cannabis Laws Are a Mess: The Politics and Bureaucracy with Jeff Guillot

Stop Ignoring Germany’s Massive Opportunity – Europe is Coming! ft. Jamie Pearson

Navigating the Gray: The Legal Tightrope of Cannabis Risk & Compliance ft. Dan Shapiro

Chris Violas Breaks Down Blaze’s Software Infrastructure

Inside Curio Wellness with Wendy Bronfein: Maryland vs. Missouri Cannabis Markets and Crohn’s Treatment

Sundie Seefried: Bank Secrecy, Hemp vs. Cannabis Banking, and Credit Card Barriers – What You Need to Know for the Future